COL1A1 and myocardial infarction: Two matrikines are derived from COL1A1: DGGRYY peptide that can inhibit human neutrophil activation by collagen (68), and COL1 matricryptin p1158/1159 that has recently shown promising results in generating new ECM and stimulating angiogenesis post myocardial infarction (69).